Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 341

Chronic Pain Clinical Trials Data Patients 341

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Threat to Patient Access in Oregon.

Access 52

Access Patients Research and Development Treatment 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

United Patients Group

JUNE 8, 2023

A high-quality patient experience is paramount in any healthcare setting. Satisfied patients are more likely to trust their healthcare providers. It encourages patients to ask questions, provide accurate information, and participate in shared decision-making, leading to better treatment adherence and overall care quality.

Patients 52

Patients Data Collective Environment 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52

Data Treatment Patients Chronic Pain 52

Veriheal

DECEMBER 14, 2021

An Analysis of Nationwide EVALI Data. Additionally, this one policy change made the odds of vaping as the primary form of consumption 40% lower, demonstrating that patients were ready and willing to switch from vaping to smoking home-grown cannabis once they were able.

Data 98

Data Vaping Legalization Consumption 98

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data 100

Data Research and Development Patients Strains 100

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 243

Chronic Pain Therapy Patients Topical 243

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.

Programs 72

Programs Patients Dispensary Cultivation 72

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis to treat ankylosing spondylitis and psoriatic arthritis among many other autoimmune conditions, mental health and the effects of chronic inflammation. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

MMJ Recs

JUNE 15, 2022

Medical marijuana (MMJ) is used to treat pain from a wide variety of conditions or illnesses, including everything from chronic back pain to arthritis. The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual.

Patients 52

Patients Treatment Clinical Trials Therapy 52

NewsMunchies

JULY 10, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. Using AI-powered medicine could allow for more effective treatment of conditions such as heart disease, cancer, and cystic fibrosis.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

AUGUST 23, 2021

They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. Cannabis is currently used to treat a wide range of conditions.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

The Cannigma

MARCH 14, 2023

And the truth was that many of the early medical cannabis patients were severely ill. Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used.

Policy 96

Policy Research and Development Conditions Consumption 96

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. It has been a go-to option for healthcare professionals seeking to manage pain effectively for their patients.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. People using illicit products were more likely to be treating mental health or sleep conditions.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ .

Patients 52

Patients Conditions Treatment Education 52

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Veriheal

DECEMBER 14, 2023

The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronic pain, anxiety, and insomnia. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

MMJ Recs

AUGUST 30, 2021

Since these beginnings in 2014, many other changes surrounding the use and possession of medical marijuana have been put into place in Missouri so the state can provide legal medical marijuana to patients suffering from a variety of approved conditions. Is medical marijuana being sold in Missouri yet?

Seed-To-Sale 98

Seed-To-Sale Business Marijuana Dispensary 98

Veriheal

AUGUST 15, 2022

The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. The sessions were logged by a total of 1,224 people who had access to the app. Promising News for Endless Patients.

Treatment 101

Treatment Research and Development Sativa Cannabinoids 101

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. This process involves various stages, including cultivation, processing, packaging, distribution, and retailing.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

FEBRUARY 9, 2023

The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.” All imaging and behavioral data will be accessible to the public after the study is complete.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. ADDITIONAL INFORMATION.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Veriheal

NOVEMBER 18, 2022

Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Let us know in the comments!

Edibles 98

Edibles Hemp Epilepsy Programs 98

Veriheal

SEPTEMBER 13, 2022

With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. Grow rooms require ventilation, lights, environmental controls, and other optimal environmental conditions in order for cannabis plants to thrive. Cultivation Costs for Homegrowers. Will you be one of them?

Cultivation 109

Cultivation Data DEA Dispensary 109